Page last updated: 2024-09-04

carbapenems and candesartan cilexetil

carbapenems has been researched along with candesartan cilexetil in 1 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(candesartan cilexetil)
Trials
(candesartan cilexetil)
Recent Studies (post-2010) (candesartan cilexetil)
7,3551475,277628151133

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)candesartan cilexetil (IC50)
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.2
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)2.4547
DNA polymerase kappaHomo sapiens (human)7.4
DNA polymerase iotaHomo sapiens (human)6.2
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.7244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Deng, X; Ding, R; Feng, H; Gao, Y; Guo, Y; Liu, H; Niu, X; Qiu, J; Wang, J; Yang, M1

Other Studies

1 other study(ies) available for carbapenems and candesartan cilexetil

ArticleYear
Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    British journal of pharmacology, 2024, Volume: 181, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Dexrazoxane; Masoprocol; Meropenem; Mice; Microbial Sensitivity Tests

2024